系统性红斑狼疮患者疾病活动性评估及监测

doi:10.16150/j.1671-2870.2018.05.026

摘要/Abstract

中图分类号:

R593.24

奚慧琴, 金艳, 潘蕾, 沈晓炜. 系统性红斑狼疮患者疾病活动性评估及监测[J]. 诊断学理论与实践, 2018, 17(05): 616-619.

[1] Barr SG, Zonana-Nacach A, Magder LS, et al.Patterns of disease activity in systemic lupus erythematosus[J]. Arthritis Rheum,1999,42(12):2682-2688.
[2] 吴建农, 陈顺乐. 系统性红斑狼疮50例10年预后及其影响因素分析[J]. 中国实用内科杂志,2006,26(11):841-842.
[3] van Vollenhoven R, Voskuyl A, Bertsias G, et al. A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)[J]. Ann Rheum Dis,2017,76(3):554-561.
[4] Yee CS, Isenberg DA, Prabu A, et al.BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000[J]. Ann Rheum Dis,2008,67(6):873-876.
[5] Romero-Diaz J, Isenberg D, Ramsey-Goldman R.Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI)[J]. Arthritis Care Res (Hoboken),2011,63(Suppl 11):S37-S46.
[6] Yazdany J, Yelin EH, Panopalis P, et al.Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort[J]. Arthritis Rheum,2008, 59(1):136-143.
[7] Pettersson S, Lövgren M, Eriksson LE, et al.An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life[J]. Scand J Rheumatol,2012,41(5):383-390.
[8] Pettersson S, Boström C, Eriksson K, et al.Lifestyle habits and fatigue among people with systemic lupus erythematosus and matched population controls[J]. Lupus,2015,24(9):955-965.
[9] 曾芙蓉, 徐倩云, 刘頔, 等. 系统性红斑狼疮患者生活质量影响因素分析[J]. 临床内科杂志,2017,34(6):386-390.
[10] Goldberg RJ, Urowitz MB, Ibañez D, et al.Risk factors for development of coronary artery disease in women with systemic lupus erythematosus[J]. J Rheumatol,2009, 36(11):2454-2461.
[11] Weinstein PK, Amirkhosravi A, Angelopoulos TJ, et al.Reducing cardiovascular risk in women with lupus: perception of risk and predictors of risk-reducing behaviors[J]. J Cardiovasc Nurs,2014,29(2):130-139.
[12] Shen B, Feng G, Tang W, et al.The quality of life in Chinese patients with systemic lupus erythematosus is associated with disease activity and psychiatric disorders: a path analysis[J]. Clin Exp Rheumatol,2014,32(1):101-107.
[13] Abdul-Sattar AB, Abou El Magd SA. Determinants of medication non-adherence in Egyptian patients with systemic lupus erythematosus: Sharkia Governorate[J]. Rheumatol Int,2015,35(6):1045-1051.
[14] Mohamed DF, Habeeb RA, Hosny SM, et al.Incidence and risk of infection in egyptian patients with systemic lupus erythematosus[J]. Clin Med Insights Arthritis Musculoskelet Disord,2014,7:41-48.
[15] 孟庆霞. 系统性红斑狼疮患者医院感染32例护理分析[J]. 航空航天医学杂志,2018,29(1):124-125.
[16] Vinet E, Labrecque J, Pineau CA, et al.A population-based assessment of live births in women with systemic lupus erythematosus[J]. Ann Rheum Dis,2012,71(4):557-579.
[17] Clowse ME.Lupus activity in pregnancy[J]. Rheum Dis Clin North Am,2007,33(2):237-252.
[18] 吕良敬, 倪若柠. 重视复发性流产患者中未分化结缔组织病的诊断[J]. 诊断学理论与实践,2018,17(3):235-237.
[19] 沈明虹, 杨茵, 孙阳. 系统性红斑狼疮妊娠时机选择在改善妊娠结局中的意义[J]. 山西医科大学学报,2015,46(4):340-343.
[20] Khamashta MA.Systemic lupus erythematosus and pregnancy[J]. Best Pract Res Clin Rheumatol,2006,20(4):685-694.
[21] Iozza I, Cianci S, Di Natale A, et al.Update on systemic lupus erythematosus pregnancy[J]. J Prenat Med,2010,4(4):67-73.
[22] Ruiz-Irastorza G, Khamashta MA, Gordon C, et al.Measuring systemic lupus erythematosus activity during pregnancy: validation of the lupus activity index in pregnancy scale[J]. Arthritis Rheum,2004,51(1):78-82.
[23] Braun J, van den Berg R, Baraliakos X, et al. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis[J]. Ann Rheum Dis,2011,70(6):896-904.

系统性红斑狼疮患者疾病活动性评估及监测

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	王麒钧, 朱海琴, 潘萌. 天疱疮主要自身抗体及其检测临床意义研究进展[J]. 诊断学理论与实践, 2022, 21(05): 638-643.
[2]	中国高血压联盟《动态血压监测指南》委员会. 2020中国动态血压监测指南[J]. 诊断学理论与实践, 2021, 20(01): 21-36.
[3]	张伯玮, 任静, 马睿, 门剑龙. D-二聚体在静脉血栓栓塞症诊疗中的应用临床实践[J]. 诊断学理论与实践, 2020, 19(05): 469-473.
[4]	黄永艳, 杨丽娜, 曹久妹, 王巍. 基于云数据的门诊高血压监测[J]. 诊断学理论与实践, 2020, 19(03): 319-324.
[5]	徐婷嬿, 杨龑, 李晶晶, 张冬燕, 王颖, 王继光, 李燕. 24 h动态血压变异与心脏结构和功能的关系[J]. 诊断学理论与实践, 2019, 18(2): 193-198.
[6]	中国高血压联盟《家庭血压监测指南》委员会. 2019中国家庭血压监测指南[J]. 诊断学理论与实践, 2019, 18(03): 258-262.
[7]	葛建华, 龚文, 施新明, 巩惠芸, 马龙新, 周劲峰, 石慧. ELISA法联合CLIFT法检测抗双链DNA-IgG抗体应用于系统性红斑狼疮的诊断价值[J]. 诊断学理论与实践, 2018, 17(06): 658-663.
[8]	严振鹏, 杨月嫦, 吴惠涓, 陈坤, 徐云霞. 1例多方案评估帕金森病睡眠障碍治疗疗效的病例报告[J]. 诊断学理论与实践, 2018, 17(04): 457-459.
[9]	扶琼, 吕良敬. 1971年到2017年系统性红斑狼疮分类标准的发展和比较[J]. 诊断学理论与实践, 2018, 17(03): 249-253.
[10]	卢红娟, 吴歆, 周凌, 赵娟, 徐沪济. 强直性脊柱炎合并系统性红斑狼疮病例报告1例[J]. 诊断学理论与实践, 2018, 17(03): 341-343.
[11]	李燕, 张冬燕. 重视隐匿性高血压的筛查诊断与治疗[J]. 诊断学理论与实践, 2017, 16(06): 571-575.
[12]	宋陆茜, 常春康. 二代测序技术在骨髓增生异常综合征诊治中的临床应用[J]. 诊断学理论与实践, 2016, 15(06): 556-560.
[13]	李卫平, 施若非,. 抗核抗体谱检测在系统性红斑狼疮诊断中的临床价值[J]. 诊断学理论与实践, 2015, 14(06): 545-548.
[14]	陆一闻, 潘秀军, 郑英霞, 沈立松,. 系统性红斑狼疮患者的白细胞介素17阳性调节性T细胞对B细胞的存活及抗体分泌的调节[J]. 诊断学理论与实践, 2015, 14(06): 528-532.
[15]	马建芳, 孙治坤, 潘萌, 李根, 汤荟冬,. 系统性红斑狼疮的中枢神经系统表现特征[J]. 诊断学理论与实践, 2015, 14(03): 229-234.